A Genomic Signature of Influenza Infection Shows Potential for Presymptomatic Detection, Guiding Early Therapy, and Monitoring Clinical Responses
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Early, presymptomatic intervention with oseltamivir (corresponding to the onset of a published host-based genomic signature of influenza infection) resulted in decreased overall influenza symptoms (aggregate symptom scores of 23.5 vs 46.3), more rapid resolution of clinical disease (20 hours earlier), reduced viral shedding (total median tissue culture infectious dose [TCID50] 7.4 vs 9.7), and significantly reduced expression of several inflammatory cytokines (interferon-γ, tumor necrosis factor-α, interleukin-6, and others). The host genomic response to influenza infection is robust and may provide the means for early detection, more timely therapeutic interventions, a meaningful reduction in clinical disease, and an effective molecular means to track response to therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Panels containing a limited number of host biomarkers are being developed as diagnostic assays for influenza77, tuberculosis70 and bacterial sepsis78.”
From Clinical metagenomics (2019) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Hayden, F. G., Treanor, J. J., Fritz, R. S., Lobo, M., Betts, R. F., Miller, M., Kinnersley, N., Mills, R. G., Ward, P., & Straus, S. E. (1999) · JAMA · doi:10.1001/jama.282.13.1240 · Cited by 550 · cited 1×
“given oseltamivir at a defined timepoint 28 hours after inoculation [7] and confirms that earlier intervention shows promise for improved clinical outcomes in influenza infection.”
BackgroundKaiser, L., Wat, C., Mills, T., Mahoney, P., Ward, P., & Hayden, F. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.14.1667 · Cited by 501
Zaas, A. K., Chen, M., Varkey, J., Veldman, T., Hero, A. O., Lucas, J., Huang, Y., Turner, R., Gilbert, A., Lambkin-Williams, R., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.07.006 · Cited by 421 · cited 1×
“After 24 hours in quarantine, we instilled 10(6) of median tissue culture infectious dose (TCID50) influenza A into bilateral nares of subjects using standard methods [12].”
MethodSelf-citationWoods, C. W., McClain, M. T., Chen, M., Zaas, A. K., Nicholson, B. P., Varkey, J., Veldman, T., Kingsmore, S. F., Huang, Y., Lambkin-Williams, R., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0052198 · Cited by 183 · cited 3×
“0 Arrays (Affymetrix, Santa Clara, CA) as previously described [11, 13] (see Supplementary Methods for full experimental details).”
BackgroundMethodSelf-citationFry, A. M., Goswami, D. R., Nahar, K., Sharmin, A. T., Rahman, M., Gubareva, L. V., Azim, T., Bresee, J., Luby, S. P., & Brooks, W. A. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70267-6 · Cited by 157 · cited 1×
“however, little is known about how such treatment effects molecular markers of host recovery [9, 10].”
BackgroundA Host-Based RT-PCR Gene Expression Signature to Identify Acute Respiratory Viral Infection
Zaas, A. K., Burke, T., Chen, M., McClain, M., Nicholson, B., Veldman, T., Tsalik, E. L., Fowler, V., Rivers, E. P., Otero, R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006280 · Cited by 139 · cited 7×
“We obtained nasal lavage samples from each subject daily for qualitative viral culture and and/or quantitative influenza reverse transcription-polymerase chain reaction (RT-PCR) to assess the success and timing of infection [14].”
BackgroundMethodSelf-citationGene-expression profiling of peripheral blood mononuclear cells in sepsis*
Tang, B. M. P., McLean, A. S., Dawes, I. W., Huang, S. J., & Lin, R. C. Y. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819b52fd · Cited by 137
Ng, S., Cowling, B. J., Fang, V. J., Chan, K. H., Ip, D., Cheng, C. K. Y., Uyeki, T. M., Houck, P. M., Peiris, M. J. S., & Leung, G. M. (2010) · Clinical Infectious Diseases · doi:10.1086/650458 · Cited by 121 · cited 1×
“however, little is known about how such treatment effects molecular markers of host recovery [9, 10].”
BackgroundGene-expression profiling of peripheral blood mononuclear cells in sepsis
Tang, B. M. P., McLean, A. S., Huang, S., Dawes, I. W., & Lin, R. C. Y. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181a9ef74 · Cited by 111
Cited by
Chiu, C. Y., & Miller, S. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0113-7 · Cited by 1,620
Dysregulated transcriptional responses to SARS-CoV-2 in the periphery
McClain, M. T., Constantine, F. J., Henao, R., Liu, Y., Tsalik, E. L., Burke, T. W., Steinbrink, J. M., Petzold, E., Nicholson, B. P., Rolfe, R. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21289-y · Cited by 134
Self-citationNew Molecular Diagnostic Approaches to Bacterial Infections and Antibacterial Resistance
Tsalik, E. L., Bonomo, R. A., & Fowler, V. G. (2018) · Annual Review of Medicine · doi:10.1146/annurev-med-052716-030320 · Cited by 74
Self-citationLambkin‐Williams, R., Noulin, N., Mann, A., Catchpole, A. P., & Gilbert, A. S. (2018) · Respiratory Research · doi:10.1186/s12931-018-0784-1 · Cited by 58
“In recent years it has been used to demonstrate “gene switching signatures” that could form part of a diagnostic that would reveal infected individuals before they become symptomatic, in the early stages of infection; this could be vitally important in the event of a pandemic [176, 177].”
MethodSelf-citationMcClain, M. T., Constantine, F. J., Nicholson, B. P., Nichols, M., Burke, T. W., Henao, R., Jones, D. C., Hudson, L. L., Jaggers, L. B., Veldman, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30486-2 · Cited by 44
Self-citationThe effective rate of influenza reassortment is limited during human infection
Leonard, A. S., McClain, M. T., Smith, G. J. D., Wentworth, D. E., Halpin, R., Lin, X., Ransier, A., Stockwell, T. B., Das, S. R., Gilbert, A. S., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006203 · Cited by 50
Self-citationTranscriptomics in Human Challenge Models
Barton, A., Hill, J. W., Pollard, A. J., & Blohmke, C. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01839 · Cited by 34
Host-Based Diagnostics for Acute Respiratory Infections
Ross, M. H., Zick, B., & Tsalik, E. L. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.06.007 · Cited by 37
Self-citationAtallah, J., & Mansour, M. K. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.805107 · Cited by 36
The host response as a tool for infectious disease diagnosis and management
Lydon, E., Ko, E. R., & Tsalik, E. L. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1493378 · Cited by 29
“showed that administration of antiviral medications at the time of transcriptomic divergence before symptoms successfully mitigated symptoms, length of illness, and expression of inflammatory cytokines [134].”
BackgroundSelf-citationTsalik, E. L., Petzold, E., Kreiswirth, B. N., Bonomo, R. A., Banerjee, R., Lautenbach, E., Evans, S. R., Hanson, K. E., Klausner, J. D., Patel, R., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw831 · Cited by 28
Self-citationA miRNA Host Response Signature Accurately Discriminates Acute Respiratory Infection Etiologies
Poore, G. D., Ko, E. R., Valente, A. M., Henao, R., Sumner, K. M., Hong, C., Burke, T. W., Nichols, M., McClain, M. T., Huang, E. S., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02957 · Cited by 26
Self-citationFourati, S., Talla, A., Mahmoudian, M., Burkhart, J. G., Klén, R., Henao, R., Yu, T. V., Aydın, Z., Yeung, K. Y., Ahsen, M. E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06735-8 · Cited by 23
Self-citationGenomic Signature in Evolutionary Biology: A Review
de la Fuente, R., Díaz-Villanueva, W., Arnau, V., & Moyá, A. (2023) · Biology · doi:10.3390/biology12020322 · Cited by 27
Nasopharyngeal Protein Biomarkers of Acute Respiratory Virus Infection
Burke, T. W., Henao, R., Soderblom, E. J., Tsalik, E. L., Thompson, J. W., McClain, M. T., Nichols, M., Nicholson, B. P., Veldman, T., Lucas, J. E., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.02.015 · Cited by 18
“Our previous demonstration of thepotential for host response-based pre-symptomatic detection of H3N2 infection using blood RNA expression (McClain et al., 2016) raises the intriguing possibility that an NPL protein host response assaymight be useful in early detection of ARV infection, and should…”
BackgroundMethodInfluentialSelf-citationHarnessing the host response for precision infectious disease diagnosis
Woodhouse, E. W., McClain, M. T., & Woods, C. W. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00078-24 · Cited by 27
“Conserved genomic responses can be used to correctly classify individuals with a broad array of naturally acquired respiratory viral infections well before the time when they would present for clinical evaluation and even before detectable viral shedding begins for most subjects (184, 185).”
Self-citationHolcomb, Z. E., Steinbrink, J. M., Zaas, A. K., Betancourt-Quiroz, M., Tenor, J. L., Toffaletti, D. L., Alspaugh, J. A., Perfect, J. R., & McClain, M. T. (2022) · Journal of Fungi · doi:10.3390/jof8050430 · Cited by 12
“While in our prior work early transcriptomic signatures offer even better diagnostic performance at the time of maximal clinical disease [25,66], we did not have the opportunity to definitively assess this in the current work.”
BackgroundSelf-citationSchlaberg, R., Barrett, A., Edes, K., Graves, M., Paul, L., Rychert, J. A., Lopansri, B. K., & Leung, D. T. (2018) · REFORESTA · doi:10.20411/pai.v3i2.250 · Cited by 15
Steinbrink, J. M., Liu, Y., Henao, R., Tsalik, E. L., Ginsburg, G. S., Ramsburg, E. A., Woods, C. W., & McClain, M. T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0311007 · Cited by 10
Self-citationFalsey, A. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801496-7.00009-5 · Cited by 7
“Influenza challenge studies clearly show a definable transcriptomic profile in the blood prior to the onset of symptoms offering the possibility of earlier and more effective oseltamivir treatment [77, 98].”
BackgroundAspiring to precision medicine for infectious diseases in resource limited settings
Schully, K. L., & Clark, D. V. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801496-7.00008-3 · Cited by 6
Using machine learning to determine the time of exposure to infection by a respiratory pathogen
Sharma, K., Aminian, M., Ghosh, T., Liu, X., & Kirby, M. J. L. (2023) · Scientific Reports · doi:10.1038/s41598-023-30306-7 · Cited by 3
Colón-López, D. D., Stefan, C. P., & Koehler, J. W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801496-7.00010-1 · Cited by 4
“These processes result in measurable changes in the relative expression levels of coding and non-coding RNA and protein, even when an infection is asymptomatic [61] [62] [63] [64] [65] or difficult to diagnose [66] .”
BackgroundExplorations in Very Early Prognosis of the Human Immune Response to Influenza
Chaturvedi, M., Ghosh, T., Kirby, M. J. L., Liu, X., Ma, X., & Stiverson, S. (2016) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/2975167.2985686 · Cited by 2
“In two previous studies, healthy volunteers were inoculated with either H3N2 [7] or H1N1 [4] and monitored for development of illness.”
BackgroundOmic approaches to infectious disease testing
Mahle, R. E., & Tsalik, E. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00042-3 · Cited by 4
Self-citationKiseļova, T., Vilne, B., Zvigule-Neidere, G., & Gardovska, D. (2026) · Scientific Reports · doi:10.1038/s41598-026-67949-1 · Cited by 1
Overview: Genomic and precision medicine for infectious and inflammatory disease
Woods, C. W., & Tsalik, E. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801496-7.00001-0
Self-citationUnraveling the lung metatranscriptome in HCT
Waghmare, A., & Gharib, S. A. (2021) · Blood · doi:10.1182/blood.2020010539
Metadata
- Authors
- McClain, M. T., Nicholson, B. P., Park, L. P., Liu, T.-Y., Hero, A. O., Tsalik, E. L., Zaas, A. K., Veldman, T., Hudson, L. L., Lambkin-Williams, R., Gilbert, A., Burke, T., Nichols, M., Ginsburg, G. S., & Woods, C. W.
- Affiliations
- Duke University (US)
- Veterans Health Administration (US)
- National Center for Genome Resources (US)
- University of Michigan (US)
- hVIVO, London, United Kingdom
- hVIVO (United Kingdom) (GB)
- Corresponding author
- McClain, Micah T.
- ORCID
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-01-01
- Volume
- 3
- Issue
- 1
- Pages
- ofw007-ofw007
- ISSN
- 2328-8957 (ISSN-L)
- PMC
- PMC4771939
- OpenAlex
- W2256139303
- Cited by
- 28
- References
- 15
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 6 · 2018: 6 · 2017: 3 · 2016: 2
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Open Forum Infectious Diseases (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Veteran's Affairs Medical Center (1IK2CX000611)
- Defense Advanced Research Projects Agency (lN66001-07-C-0092)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- influenza, presymptomatic detection, oseltamivir, antiviral therapy, viral shedding, inflammatory cytokines, interferon-gamma, TNF-α, interleukin-6, host immune response
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.